Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Details
Primerjava pogojev naložbenega življenjskega zavarovanja : diplomsko delo
ID
Klančar, Miha
(
Author
),
ID
Penger, Sandra
(
Mentor
)
More about this mentor...
URL - Presentation file, Visit
http://www.cek.ef.uni-lj.si/u_diplome/klancar3174.pdf
Image galllery
Language:
Slovenian
Keywords:
Slovenija
,
zavarovalstvo
,
življenjsko zavarovanje
,
investicije
,
ponudba
,
komparacije
,
analiza
Work type:
Undergraduate thesis
Typology:
2.11 - Undergraduate Thesis
Organization:
EF - School of Economics and Business
Place of publishing:
Ljubljana
Publisher:
[M. Klančar]
Year:
2008
Number of pages:
50 str.
PID:
20.500.12556/RUL-12522
UDC:
368
COBISS.SI-ID:
17658086
Publication date in RUL:
11.07.2014
Views:
1439
Downloads:
158
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
KLANČAR, Miha, 2008,
Primerjava pogojev naložbenega življenjskega zavarovanja : diplomsko delo
[online]. Bachelor’s thesis. Ljubljana : M. Klančar. [Accessed 31 March 2025]. Retrieved from: http://www.cek.ef.uni-lj.si/u_diplome/klancar3174.pdf
Copy citation
Share:
Secondary language
Language:
Unknown
Keywords:
Slovenia
,
insurance
,
life insurance
,
investments
,
supply
,
comparisons
,
analysis
Similar documents
Similar works from RUL:
Review of the treatment of advanced non-small-cell lung cancer patients with mutation in the epidermal growth factor during the years of 2010 and 2014 at the University Clinic Golnik
Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
Similar works from other Slovenian collections:
Epidermal growth factor receptor mutations and treatment of non-small-cell lung cancer
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Multicenter evaluation of the fully automated PCR-based Idylla EGFR Mutation Assay on formalin-fixed, paraffin-embedded Q1 tissue of human lung cancer
Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer
Back